Nestlé NSRGY, the global food, beverage and nutrition powerhouse, traded at $96.2901 as it committed 2 billion reais, or roughly $393 million, to Brazil’s health-and-nutrition market through 2028. The centerpiece is a 600 million-real infant-formula factory in Minas Gerais—a direct bet on producing more locally and importing less.
The project sits inside Nestlé’s much larger 7 billion-real Brazilian investment program. Construction is scheduled to begin in 2027, with production targeted for 2028. If execution stays on track, the factory could strengthen domestic supply, reduce import dependence and position Brazil as an export base. Nestlé is not simply adding another plant. It is tightening the supply chain around a premium category with durable demand.
Still, the payoff will not arrive tomorrow. The factory consumes 30% of the nutrition budget but only 8.6% of the total Brazilian investment plan, making utilization and premium-formula demand the real tests. Nestlé’s half-year results show that it has the financial muscle to build. At $96.2901, the stock stands 6.09% below its $102.53 GF Value™, leaving a modest valuation gap for investors who believe the Brazilian expansion can deliver.